Scientists report that they have developed a novel compound that appears to protect mice against developing movement problems associated with Parkinson’s disease (PD).
The research, which could one day in the future translate into a therapy that could halt the progression of PD and thereby prevent the symptoms of the disease, appears in ACS’ Journal of Medicinal Chemistry.
Onyou Hwang, Ki Duk Park and colleagues explain that PD, which affects an estimated 4 million to 10 million people worldwide, is a progressive movement disorder with no known cure. It often starts with slight tremors and gets worse over time. Muscles go stiff. Walking becomes difficult. Speech is slurred. No one knows for certain what causes the disease, but research has shown that it’s linked with the loss of nerve cells in the brain that secrete dopamine, a chemical that is involved in movement and emotion. To find a potential new therapy for PD, the research team searched for a way to shield these brain cells.
They made 56 compounds and tested them to see which ones boosted the production of proteins that protect dopamine-releasing neurons from damage. Of those, one, which they call “12g,” proved to be the most active. Interestingly, it protected mice from developing PD-like symptoms in one laboratory test. “Taken together, 12g was found to effectively prevent the motor deficits that are associated with PD,” they say.
The Latest on: Parkinson’s disease
via Google News
The Latest on: Parkinson’s disease
- Mix Talent Sponsors Inaugural 5KforJK Event Which Raises More than $93,000 for Parkinson's Researchon October 15, 2021 at 1:21 pm
It started out as a small idea with a few friends. When Jessica Krauser, now 39, was diagnosed with Young Onset Parkinson's Disease at 37 her friends wanted to do something to help. "We really just ...
- Minor Hallucinations Common, Impactful in Parkinson Diseaseon October 15, 2021 at 12:00 pm
More than 1 in 3 patients with Parkinson disease were found to experience minor hallucinations, which were linked with worse quality of life and poor sleep outcomes.
- Billy Connolly issues heartbreaking update on Parkinson's diseaseon October 15, 2021 at 10:47 am
Sir Billy Connolly has issued an heartbreaking update on his Parkinson's disease. The comedian will tell fans he has lost the ability to write on BBC's The Graham Norton Show tonight (Friday October ...
- Study Identifies New Genes Tied to Higher Risk for Parkinson Diseaseon October 15, 2021 at 8:25 am
Researchers sought to identify candidate casual genes for Parkinson disease by integrating the genome-wide association study results with large-scale expression quantitative trait loci in 13 brain ...
- Manufacturing Commences on Adhera’s MLR-1019 for Phase 2a Clinical Trial Treating Parkinson’s Diseaseon October 15, 2021 at 7:21 am
IP Estate Grows with New Korean Patent Issued Baton Rouge, LA, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCPK: ATRX) ("Adhera" or the "Company"), a clinical stage biopharmaceutical ...
- Billy Connolly 'Heartbroken' Over Losing The Ability To Write Due To Parkinson's Diseaseon October 15, 2021 at 3:57 am
Sir Billy Connolly has admitted it “breaks his heart” to have lost the ability to write as a result of his Parkinson’s disease. The comedian was diagnosed with the condition in 2013, and has since ...
- Billy Connolly says Parkinson’s disease has left him no longer able to writeon October 15, 2021 at 3:27 am
Comedian Billy Connolly has revealed that he is no longer able to write due to Parkinson’s disease. The revered Scottish entertainer recorded an appearance on the latest episode of The Graham Norton ...
- HealthWell Opens Fund to Help Parkinson’s Patients With Psychosison October 14, 2021 at 10:00 pm
The HealthWell Foundation has opened a fund to support people with Parkinson’s or other neurocognitive diseases in the U.S. who also are being treated for psychosis. To be eligible, patients must have ...
- Art Therapy Linked to Slowed Parkinson's Progressionon October 14, 2021 at 12:27 pm
Adding art therapy to standard drug treatment in Parkinson's disease not only improves severity of both motor and nonmotor symptoms, but also slows rates of disease progression, new research suggests.
- Research shows promising results for Parkinson's treatmenton October 9, 2021 at 1:00 am
A new study suggests that treating Parkinson's disease by delivering short bursts of electrical stimulation may be an effective option.
via Bing News